{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:40:55Z","timestamp":1787020855526,"version":"build-2736575974"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13104-015-1348-9","type":"journal-article","created":{"date-parts":[[2015,9,14]],"date-time":"2015-09-14T22:50:52Z","timestamp":1442271052000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Kaposi\u2019s sarcoma: a 10-year experience with 248 patients at a single tertiary care hospital in Tanzania"],"prefix":"10.1186","volume":"8","author":[{"given":"Phillipo L.","family":"Chalya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fidelis","family":"Mbunda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter F.","family":"Rambau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyasinta","family":"Jaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nestory","family":"Masalu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Mirambo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha F.","family":"Mushi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel E.","family":"Kalluvya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,15]]},"reference":[{"key":"1348_CR1","first-page":"1069","volume":"47","author":"MB Kagu","year":"2006","unstructured":"Kagu MB, Nggada HA, Garandawa HI, Askira BH, Durosinmi MA. AIDS-associated Kaposi\u2019s sarcoma in Northeastern Nigeria. Singapore Med J. 2006;47:1069\u201374.","journal-title":"Singapore Med J"},{"key":"1348_CR2","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1515\/BC.2002.149","volume":"383","author":"D Bisacchi","year":"2002","unstructured":"Bisacchi D, Noonan DM, Carlone S, Albini A, Pfeffer U. Kaposi\u2019s sarcoma and human chorionic gonadotropin: mechanisms, moieties and mysteries. Biol Chem. 2002;383:1315\u201320.","journal-title":"Biol Chem"},{"key":"1348_CR3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF01830024","volume":"4","author":"M Kaposi","year":"1872","unstructured":"Kaposi M. Idiopathic multiple pigmented lesions of the skin. Arch Dermatol Syph. 1872;4:265\u201373.","journal-title":"Arch Dermatol Syph"},{"key":"1348_CR4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000227312","volume":"51","author":"ME Stein","year":"1994","unstructured":"Stein ME, Spencer D, Ruff P, Lakier R, MacPhail P, Bezwoda WR. Endemic African Kaposi sarcoma: clinical and therapeutic implications, 10-year experience in Johannesburg Hospital (1980\u20131990). Oncology. 1994;51:63\u20139.","journal-title":"Oncology"},{"key":"1348_CR5","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/1097-0215(20001101)88:3<489::AID-IJC25>3.0.CO;2-Q","volume":"88","author":"F Sitas","year":"2000","unstructured":"Sitas F, Pacella-Norman R, Carrara H, Patel M, Ruff P, Sur R, Jentsch U, Hale M, Rowji P, Saffer D, Connor M, Bull D, Newton R, Beral V. Spectrum of HIV-I related cancers in South Africa. Int J Cancer. 2000;88:489\u201392.","journal-title":"Int J Cancer"},{"key":"1348_CR6","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0190-9622(81)80010-2","volume":"5","author":"AE Friedman-Kien","year":"1981","unstructured":"Friedman-Kien AE. Disseminated Kaposi\u2019s sarcoma syndrome in young homosexual men. J Am Acad Dermatol. 1981;5:468\u201371.","journal-title":"J Am Acad Dermatol"},{"key":"1348_CR7","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0889-8588(03)00042-X","volume":"17","author":"E Susan","year":"2003","unstructured":"Susan E. Therapy of AIDS-associated Kaposi\u2019s sarcoma: targeting pathogenetic mechanisms. Hematol Oncol Clin N Am. 2003;17:763\u201383.","journal-title":"Hematol Oncol Clin N Am"},{"key":"1348_CR8","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/DAD.0b013e3181b7f6a7","volume":"32","author":"PJ O\u2019Donnell","year":"2010","unstructured":"O\u2019Donnell PJ, Pantanowitz L, Grayson W. Unique histologic variants of cutaneous Kaposi sarcoma. Am J Dermatopathol. 2010;32:244\u201350.","journal-title":"Am J Dermatopathol"},{"key":"1348_CR9","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/modpathol.3800061","volume":"17","author":"RM Patel","year":"2004","unstructured":"Patel RM, Goldblum JR, Hsi ED. Immunohistochemical detection of human herpes virus-8 latent nuclear antigen-1 is useful in the diagnosis of Kaposi sarcoma. Mod Pathol. 2004;17:456\u201360.","journal-title":"Mod Pathol"},{"key":"1348_CR10","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/01.aids.0000238411.75324.59","volume":"20","author":"EA Engels","year":"2006","unstructured":"Engels EA, Pfeiffer RM, Goedert JJ, Virgo P, McNeel TS, Scoppa SM, et al. Trends in cancer risk among people with AIDS in the United States 1980\u20132002. AIDS. 2006;20:1645\u201354.","journal-title":"AIDS"},{"key":"1348_CR11","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1002\/cncr.20309","volume":"100","author":"A Mocroft","year":"2004","unstructured":"Mocroft A, Kirk O, Clumeck N, Gargalianos-Kakolyris P, Trocha H, Chentsova N, et al. The changing pattern of Kaposi sarcoma in patients with HIV, 1994\u20132003: the Euro SIDA Study. Cancer. 2004;100:2644\u201354.","journal-title":"Cancer"},{"key":"1348_CR12","doi-asserted-by":"crossref","first-page":"e8621","DOI":"10.1371\/journal.pone.0008621","volume":"5","author":"AJ Sasco","year":"2010","unstructured":"Sasco AJ, Jaquet A, Boidin E, Ekouevi DK, Thouillot F, Lemabec T, et al. The challenge of AIDS-related malignancies in sub-Saharan Africa. PLoS One. 2010;5:e8621.","journal-title":"PLoS One"},{"key":"1348_CR13","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1054\/bjoc.1999.1071","volume":"82","author":"HR Wabinga","year":"2000","unstructured":"Wabinga HR, Parkin DM, Wabwire-Mangen F, Nambooze S. Trends in cancer incidence in Kyadondo County, Uganda, 1960\u20131997. Br J Cancer. 2000;82:1585\u201392.","journal-title":"Br J Cancer"},{"key":"1348_CR14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ijc.2910630107","volume":"63","author":"MT Bassett","year":"1995","unstructured":"Bassett MT, Chokunonga E, Mauchaza B, Levy L, Ferlay J, Parkin DM. Cancer in the African population of Harare, Zimbabwe, 1990\u20131992. Int J Cancer. 1995;63:29\u201336.","journal-title":"Int J Cancer"},{"key":"1348_CR15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4103\/2278-9596.117132","volume":"3","author":"A Ahmed","year":"2013","unstructured":"Ahmed A, Muktar HM, Bugaje MA. Epidemiological and clinical features of AIDS-Associated Kaposi\u2019s sarcoma in Northern Nigeria. Arch Int Surg. 2013;3:29\u201334.","journal-title":"Arch Int Surg"},{"key":"1348_CR16","first-page":"174","volume":"3","author":"BM Mandong","year":"2004","unstructured":"Mandong BM, Chirdan LB, Anyebe AO, Mannaseh AN. Histopathological study of Kaposi\u2019s sarcoma in Jos: a 16\u00a0year review. Ann Afr Med. 2004;3:174\u20136.","journal-title":"Ann Afr Med"},{"key":"1348_CR17","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1126\/science.7997879","volume":"266","author":"Y Chang","year":"1994","unstructured":"Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi\u2019s sarcoma. Science. 1994;266:1865\u20139.","journal-title":"Science"},{"key":"1348_CR18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/path.1711000307","volume":"100","author":"G Slavin","year":"1970","unstructured":"Slavin G, Cameron HM. Kaposi\u2019s sarcoma in East African children. J Pathol. 1970;100:187\u201399.","journal-title":"J Pathol"},{"key":"1348_CR19","first-page":"670","volume":"53","author":"SIC Kyalwazi","year":"1976","unstructured":"Kyalwazi SIC. Histological classification of Kaposi\u2019s sarcoma: a basis for chemotherapy. East Afr Med J. 1976;53:670\u20136.","journal-title":"East Afr Med J"},{"key":"1348_CR20","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1258\/ijsa.2008.008353","volume":"20","author":"PA Agaba","year":"2009","unstructured":"Agaba PA, Sule HM, Ojohoh RO, Hassan Z, Apena L, Muazu MA, Badung, Agbaji OO, Idoko JA, Kanki P. Presentation and survival of patients with AIDS-related Kaposi\u2019s sarcoma in Jos, Nigeria. Int J STD AIDS. 2009;20:410\u20133.","journal-title":"Int J STD AIDS"},{"key":"1348_CR21","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/00006454-200105000-00009","volume":"20","author":"H Amir","year":"2001","unstructured":"Amir H, Kaaya EE, Manji KP, Kwesigabo G, Biberfeld P. Kaposi\u2019s sarcoma before and during a human immunodeficiency virus epidemic in Tanzanian children. Pediatr Infect Dis J. 2001;20:518\u201321.","journal-title":"Pediatr Infect Dis J"},{"key":"1348_CR22","first-page":"979","volume":"1","author":"WK Urassa","year":"1998","unstructured":"Urassa WK, Kaaya EE, Kitinya JN, Lema LEK, Amir H, Luande J, Biberfeld G, Mhalu FS, Biberfeld P. Immunological profile of endemic and epidemic Kaposi\u2019s sarcoma patients in Dar-es Salaam, Tanzania. Int J Mol Med. 1998;1:979\u201382.","journal-title":"Int J Mol Med"},{"key":"1348_CR23","first-page":"1291","volume":"17","author":"AR Mwakigonja","year":"2007","unstructured":"Mwakigonja AR, Pak F, Pyakurel P, Mosha IJ, Urassa WK, Kaaya EE, Biberfeld P. Oral Kaposi\u2019s sarcoma in Tanzania: presentation, immunopathology and human herpesvirus-8 association. Oncol Rep. 2007;17:1291\u20139.","journal-title":"Oncol Rep"},{"key":"1348_CR24","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2334-9-19","volume":"9","author":"EF Lyamuya","year":"2009","unstructured":"Lyamuya EF, Aboud S, Urassa WK, Sufi J, Mbwana J, Ndungulile F, Massambu C. Evaluation of rapid HIV assays and development of national rapid HIV test algorithms in Dar es salaam, Tanzania. BMC Infect Dis. 2009;9:19.","journal-title":"BMC Infect Dis"},{"key":"1348_CR25","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1200\/JCO.1997.15.9.3085","volume":"15","author":"SE Krown","year":"1997","unstructured":"Krown SE, Testa MA, Huang J. AIDS-related Kaposi\u2019s sarcoma: prospective validation of the AIDS Clinical Trials Group staging classification.AIDS Clinical Trials Group Oncology Committee. J Clin Oncol. 1997;15:3085\u201392.","journal-title":"J Clin Oncol"},{"key":"1348_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4314\/thrb.v14i1.3","volume":"1","author":"PL Chalya","year":"2012","unstructured":"Chalya PL, Gilyoma JM, Kanumba ES, Mawala B, Masalu N, Kahima JK, Rambau P. Dermatological malignancies at a University Teaching Hospital in northwestern Tanzania: a retrospective review of 154 cases. Tanzania J Health Res. 2012;1:3. doi: 10.4314\/thrb.v14i1.3 .","journal-title":"Tanzania J Health Res"},{"key":"1348_CR27","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1365-3156.2005.01491.x","volume":"10","author":"G Sissolak","year":"2005","unstructured":"Sissolak G, Mayaud P. AIDS-related Kaposi\u2019s sarcoma: epidemiological, diagnostic, treatment and control aspects in sub-Saharan Africa. Trop Med Int Health. 2005;10:981\u201392.","journal-title":"Trop Med Int Health"},{"key":"1348_CR28","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/jnci\/94.16.1204","volume":"94","author":"MA Eltom","year":"2002","unstructured":"Eltom MA, Jemal A, Mbulaiteye SM, Devesa SS, Biggar RJ. Trends in Kaposi\u2019s sarcoma and non-Hodgkin\u2019s lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst. 2002;94:1204\u201310.","journal-title":"J Natl Cancer Inst"},{"key":"1348_CR29","first-page":"103","volume-title":"Global View of HIV Infection","author":"A Ahmed","year":"2011","unstructured":"Ahmed A, Muktar HM. Epidemiology and treatment of Kaposi\u2019s sarcoma in HIV-1 infected individuals in a poor resource setting. In: Venketaraman V, editor. Global View of HIV Infection. Croatia: InTech; 2011. p. 103\u201326."},{"key":"1348_CR30","first-page":"120","volume":"81","author":"JF Onyango","year":"2004","unstructured":"Onyango JF, Njiru A. Kaposi\u2019s sarcoma in a Nairobi Hospital. East Afr Med J. 2004;81:120\u20133.","journal-title":"East Afr Med J"},{"key":"1348_CR31","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1258\/0049475054620671","volume":"35","author":"AZ Mohammed","year":"2005","unstructured":"Mohammed AZ, Nwana EJC, Manasseh AN. Changing patterns of Kaposi sarcoma in Nigerians. Trop Doc. 2005;35:168\u20139.","journal-title":"Trop Doc"},{"key":"1348_CR32","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/004947550103100119","volume":"31","author":"A Ahmed","year":"2001","unstructured":"Ahmed A, Isa MS, Garba HA, Kalayi GD, Muhammad I, Egler LJ. Influence of HIV infection on presentation of Kaposi\u2019s sarcoma. Trop Doct. 2001;31:42\u20135.","journal-title":"Trop Doct"},{"key":"1348_CR33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/1545109706290176","volume":"5","author":"KC Iregbu","year":"2006","unstructured":"Iregbu KC, Elegba OY. Prevalence of Kaposi\u2019s sarcoma among adult HIV-seropositive patients seen in a designated HIV treatment and care center in Abuja, Nigeria. J Int Assoc Physicians AIDS Care (Chic). 2006;5:115\u20138.","journal-title":"J Int Assoc Physicians AIDS Care (Chic)"},{"key":"1348_CR34","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1258\/ijsa.2008.007301","volume":"19","author":"A Mosam","year":"2008","unstructured":"Mosam A, Hurkchand HP, Cassol E, Page T, Cassol S, Bodasing U, et al. Characteristics of HIV-1-associated Kaposi\u2019s sarcoma among women and men in South Africa. Int J STD AIDS. 2008;19:400\u20135.","journal-title":"Int J STD AIDS"},{"key":"1348_CR35","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/QAI.0b013e31802c83d9","volume":"44","author":"AL Meditz","year":"2007","unstructured":"Meditz AL, Borok M, MaWhinney S, Gudza I, Ndemera B, Gwanzura L, et al. Gender differences in AIDS-associated Kaposi sarcoma in Harare, Zimbabwe. J Acquir Immune Defic Syndr. 2007;44:306\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"1348_CR36","doi-asserted-by":"crossref","first-page":"e13936","DOI":"10.1371\/journal.pone.0013936","volume":"5","author":"W Phipps","year":"2010","unstructured":"Phipps W, Ssewankambo F, Nguyen H, Saracino M, Wald A, Corey L, et al. Gender differences in clinical presentation and outcomes of epidemic Kaposi sarcoma in Uganda. PLoS One. 2010;5:e13936.","journal-title":"PLoS One"},{"key":"1348_CR37","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4103\/1596-3519.55670","volume":"7","author":"ME Asuquo","year":"2008","unstructured":"Asuquo ME, Ogunkeyede A, Bassey EE, Ebughe G. Kaposi sarcoma: changing trend in Calabar, southeastern Nigeria. Ann Afr Med. 2008;7:98\u2013101.","journal-title":"Ann Afr Med"},{"key":"1348_CR38","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-4632.2007.03464.x","volume":"46","author":"PT Pitche","year":"2007","unstructured":"Pitche PT, Kombate K, Owono F, Tchangai-Walla K. Kaposi\u2019s sarcoma in a hospital setting in Lome (Togo): a study of 93 cases. Int J Dermatol. 2007;46:42\u20134.","journal-title":"Int J Dermatol"},{"key":"1348_CR39","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1056\/NEJM199704033361403","volume":"336","author":"S Charles","year":"1997","unstructured":"Charles S, Siegfried J, Alex EC, et al. Monoclonal origin of multicentric Kaposi\u2019s sarcoma lesions. N Engl J Med. 1997;336:988\u201393.","journal-title":"N Engl J Med"},{"key":"1348_CR40","first-page":"257","volume":"1","author":"CS Rabkin","year":"1995","unstructured":"Rabkin CS, Bedi G, Musabe E, et al. AIDS related Kaposi\u2019s sarcoma is a clonal neoplasm. Clin Cancer Res. 1995;1:257\u201360.","journal-title":"Clin Cancer Res"},{"key":"1348_CR41","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0140-6736(96)03240-0","volume":"348","author":"ET Lennette","year":"1996","unstructured":"Lennette ET, BLackbourn DT, Levy JA. Antibodies to human herpes virus type 8 in the general population and in Kaposi\u2019s sarcoma patients. Lancet. 1996;348:858\u201361.","journal-title":"Lancet"},{"key":"1348_CR42","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/nm0896-918","volume":"2","author":"DH Kedes","year":"1996","unstructured":"Kedes DH, Operskalski E, Buseh M, et al. The sero-epidemiology of herpes virus 8(Kaposi\u2019s sarcoma associated Herpes virus) distribution of infection in Kaposi\u2019s sarcoma risk group and evidence of sexual transmission. Nat Med. 1996;2:918\u201324.","journal-title":"Nat Med"},{"key":"1348_CR43","first-page":"87","volume":"6","author":"AA Otu","year":"1990","unstructured":"Otu AA. Kaposi\u2019s sarcoma: clinical, immunological and therapeutic consideration. Nigerian Med Pract. 1990;6:87\u201392.","journal-title":"Nigerian Med Pract"},{"key":"1348_CR44","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2217\/17435889.2.3.345","volume":"2","author":"U Ashish","year":"2007","unstructured":"Ashish U, Keith MS, Donald WN. Pegylated liposomal doxorubicin in the treatment of AIDS-related Kaposi\u2019s sarcoma. Int J Nanomed. 2007;2:345\u201352.","journal-title":"Int J Nanomed"},{"key":"1348_CR45","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1200\/JCO.2004.08.064","volume":"22","author":"SE Krown","year":"2004","unstructured":"Krown SE. Highly active antiretroviral therapy in AIDS-associated Kaposi\u2019s sarcoma: implications for the design of therapeutic trials in patients with advanced, symptomatic Kaposi\u2019s sarcoma. J Clin Oncol. 2004;22:399\u2013402.","journal-title":"J Clin Oncol"},{"key":"1348_CR46","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1742-6405-5-2","volume":"5","author":"L Feller","year":"2008","unstructured":"Feller L, Masipa JN, Wood NH, Raubenheimer EJ, Lemmer J. The prognostic significance of facial lymphoedema in HIV-seropositive subjects with Kaposi sarcoma. AIDS Res Therap. 2008;5:2.","journal-title":"AIDS Res Therap"},{"key":"1348_CR47","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1443-1661.2010.00994.x","volume":"22","author":"R Kibria","year":"2010","unstructured":"Kibria R, Siraj U, Barde C. Kaposi\u2019s sarcoma of the stomach and duodenum in human immunodeficiency virus infection. Dig Endosc. 2010;22:241\u20132.","journal-title":"Dig Endosc"},{"key":"1348_CR48","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJM200004063421407","volume":"342","author":"K Antman","year":"2000","unstructured":"Antman K, Chang Y. Kaposi\u2019s sarcoma. N Engl J Med. 2000;342:1027\u201338.","journal-title":"N Engl J Med"},{"key":"1348_CR49","first-page":"208","volume":"25","author":"LI Zon","year":"1988","unstructured":"Zon LI, Groopman JE. Hematologic manifestations of the human immunodeficiency virus (HIV). Semin Hematol. 1988;25:208\u201318.","journal-title":"Semin Hematol"},{"key":"1348_CR50","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/blood.V91.1.301","volume":"91","author":"PS Sullivan","year":"1998","unstructured":"Sullivan PS, Hanson DL, Chu SY, Jones JL, Ward JW. Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: results from the multistate adult and adolescent spectrum of HIV disease surveilance project. Blood. 1998;91:301\u20138.","journal-title":"Blood"},{"key":"1348_CR51","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00042560-199809010-00004","volume":"19","author":"RD Moore","year":"1998","unstructured":"Moore RD, Keruly JC, Chaisson RE. Anemia and survival in HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;19:29\u201333.","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"1348_CR52","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2174\/157016209789973619","volume":"7","author":"F Martellotta","year":"2009","unstructured":"Martellotta F, Berretta M, Vaccher E, Schioppa O, Zanet E, Tirelli U. AIDS-related Kaposi\u2019s sarcoma: state of the art and therapeutic strategies. Curr HIV Res. 2009;7:634\u20138.","journal-title":"Curr HIV Res"},{"key":"1348_CR53","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/QAI.0b013e3181fc0141","volume":"56","author":"HB Koon","year":"2011","unstructured":"Koon HB, Fingleton B, Lee JY, et al. Phase II AIDS Malignancy Consortium trial of topical halofuginone in AIDS-related Kaposi sarcoma. J Acquir Immune Defic Syndr. 2011;56:64\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"1348_CR54","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1258\/td.2007.060023","volume":"38","author":"SD Makombe","year":"2008","unstructured":"Makombe SD, Harries AD, Kwong-Leung YuJ, et al. Outcomes of patients with Kaposi\u2019s sarcoma who start antiretroviral therapy under routine programme conditions in Malawi. Trop Doct. 2008;38:5\u20137.","journal-title":"Trop Doct"},{"key":"1348_CR55","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/QAD.0b013e3282ff6275","volume":"22","author":"HQ Nguyen","year":"2008","unstructured":"Nguyen HQ, Amalia SM, Kitahata MM, Rompaey SE, Wald A, Casper C. Persistent Kaposi sarcoma in the era of HAART: characterizing the predictors of clinical response. AIDS. 2008;22:937\u201345.","journal-title":"AIDS"},{"key":"1348_CR56","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/S0959-8049(01)00106-X","volume":"37","author":"U Tirelli","year":"2001","unstructured":"Tirelli U, Bernardi D. Impact of HAART on the clinical management of AIDS-related cancers. Euro J Cancer. 2001;37:1320\u20134.","journal-title":"Euro J Cancer"},{"key":"1348_CR57","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/QAI.0b013e3181fdc928","volume":"56","author":"M Guadalupe","year":"2011","unstructured":"Guadalupe M, Pollock BH, Westbrook S, et al. Risk factors influencing antibody responses to Kaposi\u2019s sarcoma-associated herpesvirus latent and lytic antigens in patients under antiretroviral therapy. J Acquir Immune Defic Syndr. 2011;56:83\u201390.","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-015-1348-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-015-1348-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T16:51:43Z","timestamp":1653151903000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-015-1348-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,15]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1348"],"URL":"https:\/\/doi.org\/10.1186\/s13104-015-1348-9","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733166783.793561092","asserted-by":"object"}]},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,15]]},"article-number":"440"}}